{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:27:45Z","timestamp":1776842865095,"version":"3.51.2"},"reference-count":29,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.vaccine.2021.11.020","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T12:47:10Z","timestamp":1637326030000},"page":"7584-7589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Vaccine bidding, procurement and distribution management practices in mainland China: A nationwide study"],"prefix":"10.1016","volume":"39","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaowei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2021.11.020_b0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/nyas.14235","article-title":"Vaccine innovations for emerging infectious diseases-a symposium report [J]","volume":"1462","author":"Cable","year":"2020","journal-title":"Ann N Y Acad Sci"},{"issue":"39","key":"10.1016\/j.vaccine.2021.11.020_b0010","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1016\/j.vaccine.2016.08.025","article-title":"Vaccine-preventable disease and the under-utilization of immunizations in complex humanitarian emergencies [J]","volume":"34","author":"Close","year":"2016","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2021.11.020_b0015","doi-asserted-by":"crossref","first-page":"A450","DOI":"10.1016\/j.jval.2014.08.1211","article-title":"The Economic Value of Vaccination: Why Prevention Is Wealth [J]","volume":"17","author":"Remy","year":"2014","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2021.11.020_b0020","first-page":"7","article-title":"Achievements and prospects of immunization and prevention in China [J]","volume":"06","author":"Wang","year":"1999","journal-title":"Chinese J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.11.020_b0025","article-title":"Impact of immunization programs on 11 childhood vaccine-preventable diseases in China: 1950\u20132018 [J]","volume":"2","author":"Pan","year":"2021","journal-title":"Innovation (N Y)"},{"key":"10.1016\/j.vaccine.2021.11.020_b0030","unstructured":"The State Council of China. Regulations on the management of vaccine circulation and vaccination. [Accessed on 04 Nov 2021]. Available from: http:\/\/www.gov.cn\/zwgk\/2005-05\/23\/content_275.htm."},{"key":"10.1016\/j.vaccine.2021.11.020_b0035","doi-asserted-by":"crossref","unstructured":"Xu M, Liang Z, Xu Y, Wang J. Chinese vaccine products go global: vaccine development and quality control. Expert Rev Vaccines. 2015;14(5):763\u201373. Bhutan, Cambodia, and Sri Lanka, 2017-2018 [J]. Vaccine, 2019, 37 Suppl 1(Suppl 1): A14-a9.","DOI":"10.1586\/14760584.2015.1012503"},{"key":"10.1016\/j.vaccine.2021.11.020_b0040","unstructured":"Meng Q. When will vaccine powers become vaccine powers [N]. Health news, 2009-06-30 (003)."},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.020_b0045","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s12879-018-3422-0","article-title":"The landscape of vaccines in China: history, classification, supply, and price [J]","volume":"18","author":"Zheng","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"i1750","key":"10.1016\/j.vaccine.2021.11.020_b0050","article-title":"Crackdown on illegal vaccine sales in China leads to 37 arrests [J]","volume":"352","author":"Parry","year":"2016","journal-title":"BMJ"},{"issue":"10145","key":"10.1016\/j.vaccine.2021.11.020_b0055","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0140-6736(18)31695-7","article-title":"Vaccine scandal and confidence crisis in China [J]","volume":"392","author":"Lancet","year":"2018","journal-title":"Lancet"},{"issue":"43","key":"10.1016\/j.vaccine.2021.11.020_b0060","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.1016\/j.vaccine.2020.08.039","article-title":"Changes in parents' decisions pertaining to vaccination of their children after the Changchun Changsheng vaccine scandal in Guangzhou, China [J]","volume":"38","author":"He","year":"2020","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.020_b0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/vaccines7030097","article-title":"Procurement of Category 2 Vaccines in China [J]","volume":"7","author":"Zhuang","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"8","key":"10.1016\/j.vaccine.2021.11.020_b0070","first-page":"337","article-title":"Vaccine cold chain: part 1 proper handling and storage of vaccine [J]","volume":"58","author":"Rogers","year":"2010","journal-title":"Aaohn J"},{"issue":"277","key":"10.1016\/j.vaccine.2021.11.020_b0075","article-title":"Factors associated with the exposure of vaccines to adverse temperature conditions: the case of North West region, Cameroon [J]","volume":"8","author":"Yakum","year":"2015","journal-title":"BMC Res Notes"},{"issue":"02","key":"10.1016\/j.vaccine.2021.11.020_b0080","first-page":"153","article-title":"Comparison of vaccine procurement, distribution and monitoring between China and Britain [J]","volume":"24","author":"Li","year":"2021","journal-title":"China Health Resources"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.020_b0085","doi-asserted-by":"crossref","first-page":"E33","DOI":"10.33321\/cdi.2017.41.6","article-title":"Evaluation of bacille Calmette-Guerin immunisation programs in Australia","volume":"41","author":"Khandaker","year":"2017","journal-title":"Commun Dis Intell Q Rep."},{"issue":"7","key":"10.1016\/j.vaccine.2021.11.020_b0090","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.vaccine.2013.12.029","article-title":"How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization [J]","volume":"32","author":"Mvundura","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.020_b0095","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/21645515.2019.1644883","article-title":"Current situation, causes, and countermeasures to NIP vaccine shortages in Guangzhou, China [J]","volume":"16","author":"Li","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2021.11.020_b0100","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.5302","article-title":"Changes in Incidence and Epidemiological Characteristics of Pulmonary Tuberculosis in Mainland China, 2005\u20132016 [J]","volume":"4","author":"Jiang","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2021.11.020_b0105","unstructured":"General Office of National Health and Family Planning Commission, [Accessed on 04 Aug 2021]. Available from: http:\/\/www.nhc.gov.cn\/jkj\/s3581\/201701\/a91fa2f3f9264cc186e1dee4b1f24084.shtml."},{"issue":"4","key":"10.1016\/j.vaccine.2021.11.020_b0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis[J]."},{"key":"10.1016\/j.vaccine.2021.11.020_b0115","unstructured":"Gavi. Gavi' s Business Model. [Accessed on 02 Aug 2021]. Available from: https:\/\/www.gavi.org\/about\/gavis-business-model\/."},{"issue":"2","key":"10.1016\/j.vaccine.2021.11.020_b0120","first-page":"239","article-title":"Vaccine supply: effects of regulation and competition","volume":"18","author":"Danzon","year":"2011","journal-title":"JEL"},{"key":"10.1016\/j.vaccine.2021.11.020_b0125","series-title":"Social value judgements: principles for the development of NICE guidance[M]","author":"National Institute for Health and Care Excellence","year":"2008"},{"key":"10.1016\/j.vaccine.2021.11.020_b0130","unstructured":"GAVI. Considerations for countries on targeting Gavi investments to achieve immunisation outcomes[R]. 2018."},{"issue":"5","key":"10.1016\/j.vaccine.2021.11.020_b0135","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/003335490912400517","article-title":"Evaluation of an outside-the-cold-chain vaccine delivery strategy in remote regions of western China [J]","volume":"124","author":"Ren","year":"2009","journal-title":"Public Health Rep"},{"issue":"29","key":"10.1016\/j.vaccine.2021.11.020_b0140","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1016\/j.vaccine.2015.03.042","article-title":"Outsourcing vaccine logistics to the private sector: The evidence and lessons learned from the Western Cape Province in South-Africa [J]","volume":"33","author":"Lydon","year":"2015","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2021.11.020_b0145","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.puhe.2015.04.016","article-title":"Optimizing national immunization program supply chain management in Thailand: an economic analysis [J]","volume":"129","author":"Riewpaiboon","year":"2015","journal-title":"Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21014651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21014651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:06:47Z","timestamp":1759403207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21014651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":29,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0264410X21014651"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.11.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine bidding, procurement and distribution management practices in mainland China: A nationwide study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}